Full Length Research Paper
References
|
Acharyya S, Sarkar P, Saha DR, Patra A, Ramamurthy T, Bag PK (2015). Intracellular and membrane-damaging activities of methyl gallate isolated from Terminalia chebula against multidrug-resistant Shigella spp. Journal of Medical Microbiology 64(8):901-909. |
|
|
Ahmed AZ, Satyam SM, Shetty P, D'Souza MR (2021). Methyl gallate attenuates doxorubicin-induced cardiotoxicity in rats by suppressing oxidative stress. Scientifica, 2021. |
|
|
Amato VS (2006). Tratamento da leishmaniose tegumentar americana. BEPA. Boletim Epidemiológico Paulista 3(26):2-6. |
|
|
Bacha TDJ, Jensen BB, Rodrigues DDC, Silva AMETD, Araújo AO, Geraldi KSCRDS, Franco AMR (2023). Microemulsion based on methyl 3,4,5-trihydroxybenzoate for the topical treatment of cutaneous leishmaniasis: an in vivo assay. Acta Amazonica 53:246-253. |
|
|
Behnia M, Latifi A, Rezaian M, Kharazi S, Mohebali M, Yasami S, Saghafi S, Chahardoli R, Anasori N, Torkian H, Soleimani M, Niyyati M, Kazemirad E (2021). In Vitro Activity of Pentamidine Isethionate against Trophozoite and Cyst of Acanthamoeba. Iranian Journal of Parasitology 16(4):560-566. |
|
|
Brasil MS (2017). Manual de Vigilância da Leishmaniose Tegumentar Americana. Ministério da Saúde, Secretaria de Vigilância em Saúde. 2. ed. Brasília: Editora do Ministério da Saúde. |
|
|
Burguera JL, Burguera M, Petit de Pena Y, Lugo A, Anez N (1993). Selective determination of antimony (III) and antimony (V) in serum and urine and of total antimony in skin biopsies of patients with cutaneous leishmaniasis treated with meglumine antimoniate. Journal of Trace Elements in Medicine 10:66-70. |
|
|
Camargos HS, Moreira RA, Mendanha SA, Fernandes KS, Dorta ML, Alonso A (2014). Terpenes increase the lipid dynamics in the Leishmania plasma membrane at concentrations similar to their IC50 values. PLoS One 9(8):e104429. |
|
|
Chae HS, Kang O, Choi J, Oh Y, Lee Y, Brice OO, Kwon D (2010). Methyl gallate inhibits the production of interleukin-6 and nitric oxide via down-regulation of extracellular-signal regulated protein kinase in RAW 264.7 cells. The American Journal of Chinese Medicine 38(5):973-983. |
|
|
Comandolli-Wyrepkowski CD, Jensen BB, Grafova I, Santos PAD, Barros AMC, Soares FV, Franco AMR (2017). Antileishmanial activity of extracts from Libidibia ferrea: development of in vitro and in vivo tests. Acta Amazonica, 47: 331-340. |
|
|
Dias CN, de Lima Nunes TA, de Sousa JMS, Costa LH, Rodrigues RRL, Araújo AJ, da Franca Rodrigues KA (2020). Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects. Chemico-Biological Interactions 320:109026. |
|
|
do Nascimento NRF, de Aguiar FLN, Santos CF, Costa AML, de Jesus Hardoim D, da Silva Calabrese K, Rocha MFG (2019). In vitro and in vivo leishmanicidal activity of a ruthenium nitrosyl complex against Leishmania (Viannia) braziliensis. Acta Tropica 192:61-65. |
|
|
Gordon S, Unkeless JC, Cohn ZA (1974). Induction of macrophage plasminogen activator by endotoxin syimulation and phagocytosis: evidences for a two stage process. Journal of Experimental Medicine 140(4):995-1010. |
|
|
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006). Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Medicine 3(5):e162. |
|
|
Huang CY, Chang YJ, Wei PL, Hung CS, Wang W (2021). Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. PloS One 16(3):e0248521. |
|
|
Jaffe CL, Grimaldi JG, McMahon-Pratt D (1984). The cultivation and cloning of Leishmania. In: morel, C.M- (ed), Genes and Antigens of Parasites. A Laboratory Manaual. 2ed. Fundação Oswaldo Cruz 47-91. |
|
|
Kyriazis JD, Aligiannis N, Polychronopoulos P, Skaltsounis AL, Dotsika E (2013). Leishmanicidal activity assessment of olive tree extracts. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 20(3-4):275-281. |
|
|
Lee SH, Kim JK, Kim DW, Hwang HS, Eum WS, Park J, Choi SY (2013). Antitumor activity of methyl gallate by inhibition of focal adhesion formation and Akt phosphorylation in glioma cells. Biochimica et Biophysica Acta (BBA)-General Subjects 1830:4017-4029. |
|
|
Maia-Elkhoury AN, Magalhães Lima D, Salomón OD, Puppim Buzanovsky L, Saboyá-Díaz MI, Valadas S Y, Sanchez-Vazquez MJ (2021). Interaction between environmental and socioeconomic determinants for cutaneous leishmaniasis risk in Latin America. Revista Panamericana de Salud Pública 45:e83. |
|
|
Mann S, Frasca K, Scherrer S, Henao-Martínez AF, Newman S, Ramanan P, Suarez JA (2021). A review of leishmaniasis: current knowledge and future directions. Current Tropical Medicine Reports 8:121-132. |
|
|
Mathison BA, Bradley BT (2023). Review of the clinical presentation, pathology, diagnosis, and treatment of leishmaniasis. Laboratory Medicine 54(4):363-371. |
|
|
Miranda-Verastegui C, Tulliano G, Gyorkos TW, Calderon W, Rahme E, Ward B, Matlashwski G (2009). First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. PLoS Neglected Tropical Diseases 3:e491. |
|
|
Neves LO, Talhari AC, Gadelha EPN, Silva Júnior RMD, Guerra JADO, Ferreira LCDL, Talhari S (2011). A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis. Anais Brasileiros De Dermatologia 86:1092-1101. |
|
|
Osorio E, Arango GJ, Jiménez N, Alzate F, Ruiz G, Gutiérrez D, Robledo S (2007). Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae. Journal of Ethnopharmacology 111(3):630-635. |
|
|
Passero LFD, Brunelli EDS, Sauini T, Amorim Pavani TF, Jesus JA, Rodrigues E (2021). The potential of traditional knowledge to develop effective medicines for the treatment of leishmaniasis. Frontiers in Pharmacology 12:690432. |
|
|
Peixoto JF, Gonçalves-Oliveira LF, Souza-Silva F, de Castro Côrtes LM, Finkelstein LC, Dias-Lopes G, Alves CR (2024). Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis. International Journal for Parasitology: Drugs and Drug Resistance: 100525. |
|
|
Saar Y, Ransford A, Waldman E, Mazareb S, Amin-Spector S, Jodie Plumblee J, Turco SJ, Zilberstein D (1998). Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Molecular and Biochemical Parasitology 95(1):20. |
|
|
Santiago AS, da Rocha Pita SS, Guimarães ET (2021). Tratamento da leishmaniose, limitações da terapêutica atual ea necessidade de novas alternativas: Uma revisão narrativa. Research, Society and Development 10(7):e29510716543-e29510716543. |
|
|
Sasidharan S, Saudagar P (2021). Leishmaniasis: where are we and where are we heading? Parasitology Research 120(5):1541-1554. |
|
|
Schubach AO, Conceição-Silva F (2014). Estado da Arte no tratamento da leishmaniose tegumentar Americana no Brasil. Leishmanioses do continente americano 1:391-412. |
|
|
Sundar S, Chakravarty J (2015). An update on pharmacotherapy for leishmaniasis. Expert opinion on pharmacotherapy 16(2):237-252. |
|
|
Tiwari N, Gedda MR, Tiwari VK, Singh SP, Singh RK (2018). Limitations of current therapeutic options, possible drug targets and scope of natural products in control of leishmaniasis. Mini Reviews in Medicinal Chemistry 18(1):26-41. |
|
|
Zarean M, Maraghi S, Hajjaran H, Mohebali M, Feiz-Hadad MH, Assarehzadegan MA (2015). Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis. Iranian Journal of Parasitology 10(1):19-29. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
